Success Metrics

Clinical Success Rate
88.9%

Based on 16 completed trials

Completion Rate
89%(16/18)
Active Trials
0(0%)
Results Posted
94%(15 trials)
Terminated
2(11%)

Phase Distribution

Ph phase_4
3
17%
Ph not_applicable
1
6%
Ph phase_1
6
33%
Ph phase_2
2
11%
Ph phase_3
6
33%

Phase Distribution

6

Early Stage

2

Mid Stage

9

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
6(33.3%)
Phase 2Efficacy & side effects
2(11.1%)
Phase 3Large-scale testing
6(33.3%)
Phase 4Post-market surveillance
3(16.7%)
N/ANon-phased studies
1(5.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

16 of 18 finished

Non-Completion Rate

11.1%

2 ended early

Currently Active

0

trials recruiting

Total Trials

18

all time

Status Distribution
Completed(16)
Terminated(2)

Detailed Status

Completed16
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
18
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (33.3%)
Phase 22 (11.1%)
Phase 36 (33.3%)
Phase 43 (16.7%)
N/A1 (5.6%)

Trials by Status

completed1689%
terminated211%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT06681116Not Applicable

Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation

Completed
NCT02185417Phase 3

Diuretic Comparison Project

Completed
NCT00896389Phase 4

Salt Loading and Thiazide Intervention Study

Completed
NCT00953680Phase 1

Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

Completed
NCT01103245Phase 1

Aldosterone and the Metabolic Syndrome

Completed
NCT01370655Phase 1

A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)

Completed
NCT00787605Phase 4

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus

Completed
NCT01256411Phase 2

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

Completed
NCT00886600Phase 3

A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)

Completed
NCT00871871Phase 1

Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)

Completed
NCT02276378Phase 1

Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers

Completed
NCT01176032Phase 4

ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling

Completed
NCT01259297Phase 3

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People

Terminated
NCT00386607Phase 3

A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.

Completed
NCT01302899Phase 2

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy

Terminated
NCT00671424Phase 1

A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide

Completed
NCT00396656Phase 3

Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

Completed
NCT00765674Phase 3

Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18